Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine PV processes and manage safety information more efficiently. The platform brings together global and local literature monitoring, regulatory intelligence, and adverse event management in one connected workflow.
DrugCard supports PV teams in identifying relevant safety information faster, reducing manual screening workload, and maintaining transparent, audit-ready processes. Its literature monitoring module covers 121+ countries, 2,200+ local medical sources, and 100+ languages, including both global databases such as PubMed and local, non-indexed medical journals.
The platform uses AI to support article pre-assessment, generate structured summaries, highlight relevant keywords, assist with translations, and help users prioritize publications that may require safety review. DrugCard also provides configurable workflows, automated notifications, reporting tools, QC functionality, audit trails, and case creation from literature.
With additional modules for Regulatory Intelligence and Adverse Event Database management, DrugCard helps organizations track health authority updates, centralize safety data, support E2B workflows, and improve overall pharmacovigilance operations. Built for MAHs, QPPVs, LQPPVs, CROs, regulatory teams, and PV professionals, DrugCard combines automation with human expert oversight to support compliant, scalable, and reliable drug safety management.
Description
Business intelligence in the global biopharmaceutical sector focuses on drug patent dynamics and the entry of generics. It is essential to forecast future budget needs and proactively seek out generic alternatives. Analyzing the achievements of past patent challengers provides insights into the competitive landscape and informs research directions. This analysis plays a crucial role in guiding portfolio management strategies for upcoming drug development projects. Additionally, anticipating the expiration of patents on branded drugs, pinpointing potential generic suppliers, and managing branded drug inventory effectively are vital. Furthermore, acquiring detailed formulation and manufacturing data helps in identifying key formulators, repackagers, and relabelers to streamline operations and enhance market positioning. Understanding these elements can significantly bolster strategic decision-making in the biopharmaceutical industry.
API Access
Has API
Yes
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
individual
Free Trial
Yes
Free Version
No
Pricing Details
$250 per month
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
Yes
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
DrugCard
Founded
2021
Country
Estonia
Website
drug-card.io
Vendor Details
Company Name
DrugPatentWatch
Founded
2003
Country
United States
Website
www.drugpatentwatch.com